In Other News

Disappointment for NMOSD drug listing There was no Christmas present from PBAC for people with NMOSD. The PBAC announced in late December its decision not to recommend PBS listing of eculizumab (Soliris) for the treatment of NMOSD. It said eculizumab was more effective than best supportive care in reducing relapses, however the magnitude of the ...

Already a member?

Login to keep reading.

© 2021 the limbic